241 filings
Page 7 of 13
8-K
32wsfymf
28 Oct 19
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial Results
7:05am
8-K
610k2n
30 Aug 19
Entry into a Material Definitive Agreement
4:10pm
424B5
brb w59gf63
30 Aug 19
Prospectus supplement for primary offering
4:08pm
S-8
n8ywic ow9ui
29 Jul 19
Registration of securities for employees
4:32pm
8-K
18themt4
29 Jul 19
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2019 Financial Results
4:05pm
8-K
iwh iqjim
26 Jun 19
Other Events
8:45am
8-K
84jq tuh3nrqepssqgag
13 Jun 19
Departure of Directors or Certain Officers
4:44pm
8-K
0jcr2nsrhez5k4y4z91j
6 Jun 19
Entry into a Material Definitive Agreement
5:20pm
DEFA14A
vvh52 y1n4yau5bgf
30 Apr 19
Additional proxy soliciting materials
4:07pm
UPLOAD
a8vqf9
30 Apr 19
Letter from SEC
12:00am
8-K
fau l48ut9ke4upv1
29 Apr 19
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2019 Financial Results
4:05pm
CORRESP
1m9e75oeenpt9a
29 Apr 19
Correspondence with SEC
12:00am
UPLOAD
lvxanro3v99o83dxoh4u
26 Apr 19
Letter from SEC
12:00am
PRER14A
yzz913exui3ctu
23 Apr 19
Preliminary revised proxy
2:34pm
CORRESP
38er 0v00
23 Apr 19
Correspondence with SEC
12:00am